• Thu, August 10, 2023

Raghuram Selvaraju Maintained (ADMA) at Strong Buy with Increased Target to $5 on, Aug 10th, 2023

Raghuram Selvaraju of HC Wainwright & Co., Maintained "ADMA Biologics, Inc." (ADMA) at Strong Buy with Increased Target from $4.5 to $5 on, Aug 10th, 2023.

Raghuram, nor any peers, have made any analyst calls on ADMA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍